Last updated on November 2017

Male and female subjects 18 years of age and older, who have suffered symptoms of OAB for at least 3 months, and who report an average of at least 2 incontinence episodes per day.


Brief description of study

Male and female subjects 18 years of age and older, who have suffered symptoms of OAB for at least 3 months, and who report an average of at least 2 incontinence episodes per day.

Detailed Study Description

A randomized, double-blind, Multi-Centre study to evaluate the efficacy and safety of adding Mirabegron to Solifenacon in Incontinent OAB subjects who have received Solifenacin for 4 weeks and warrant additional relief for their OAB symptoms.

Clinical Study Identifier: TX81684

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Debbie Johnson

First Urology, PSC
Jeffersonville, IN USA
  Connect »